InsiderTrades

Form 4 for MET MetLife

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001099219-24-000057 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-29 2024-02-27 MET PODLOGAR SUSAN M EVP, Chief HR Off F - Tax $69.16 -13.8K 81.7K -14% -$955.9K
DM 2024-02-29 2024-02-27 MET PODLOGAR SUSAN M EVP, Chief HR Off A - Grant — +31.0K 68.6K +82% —
D 2024-02-29 2024-02-27 MET PODLOGAR SUSAN M EVP, Chief HR Off A - Grant $0.00 +12.0K 12.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-27 F D 13,822 $69.16 81,701 D — —
2 Common Common Stock 2024-02-27 A A 26,968 — 95,523 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2024-02-27 A A 4,013 — 68,555 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Derivative Employee Stock Options (right to buy) 2024-02-27 A A 12,040 $0.00 12,040 D $69.16 · — to 2034-02-26 12,040 Common Stock (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.